Fisher & Paykel Healthcare Corporation Limited Stock Deutsche Boerse AG

Equities

FPLB

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Delayed Deutsche Boerse AG 02:10:08 2024-05-14 EDT 5-day change 1st Jan Change
15.7 EUR +0.64% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -0.64% +18.18%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 1.73B 1.05B 967M 1.43B Sales 2025 * 1.94B 1.17B 1.08B 1.6B Capitalization 16.82B 10.16B 9.39B 13.87B
Net income 2024 * 257M 155M 143M 212M Net income 2025 * 331M 200M 185M 273M EV / Sales 2024 * 9.81 x
Net Debt 2024 * 179M 108M 100M 148M Net Debt 2025 * 235M 142M 131M 194M EV / Sales 2025 * 8.78 x
P/E ratio 2024 *
65.2 x
P/E ratio 2025 *
50.3 x
Employees -
Yield 2024 *
1.37%
Yield 2025 *
1.49%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 week-0.64%
Current month+1.30%
1 month+9.09%
3 months+18.18%
6 months+33.33%
Current year+18.18%
More quotes
1 week
15.60
Extreme 15.6
15.90
1 month
14.30
Extreme 14.3
15.90
3 years
10.20
Extreme 10.2
20.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 84-12-31
Director of Finance/CFO - 19-02-28
Chief Tech/Sci/R&D Officer - 06-12-31
Members of the board TitleAgeSince
Director/Board Member 66 90-04-30
Chairman - 15-09-30
Chief Executive Officer 63 84-12-31
More insiders
Date Price Change
24-05-14 15.7 +0.64%
24-05-13 15.6 -1.27%
24-05-10 15.8 +0.64%
24-05-09 15.7 -1.26%
24-05-08 15.9 +0.63%

Delayed Quote Deutsche Boerse AG, May 14, 2024 at 02:10 am

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
28.8 NZD
Average target price
24.49 NZD
Spread / Average Target
-14.98%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW